Sign in Subscribe
Medical research

Personalized Medicine Breakthroughs in Knee Osteoarthritis Treatment

Strategic Insights

— 2 min read

Researchers from the First Affiliated Hospital, in collaboration with Heilongjiang University of Chinese Medicine, have made significant discoveries in the field of personalized medicine, specifically in the treatment of knee osteoarthritis (KOA). The study, published in the European Journal of Medical Research, examined the efficacy and safety of platelet-rich plasma (PRP) injections in KOA patients.

According to the study, KOA is a prevalent degenerative joint disorder affecting millions of elderly individuals worldwide. Despite various non-surgical and pharmacological treatments, their effectiveness is often limited by temporary symptom relief and lack of disease-modifying properties. The researchers aimed to comprehensively evaluate the efficacy and safety of PRP injections in treating KOA. Their systematic review and meta-analysis included 28 randomized controlled trials (RCTs) with a total of 3,246 KOA patients.

The study revealed that PRP injections demonstrated comparable pain relief to hyaluronic acid (HA) but superior functional improvement, especially when combined with HA. Compared to corticosteroids, PRP showed no significant difference in efficacy as monotherapy but enhanced outcomes when used in combination. Furthermore, PRP outperformed physical therapy and exercise therapy in both pain control and functional improvement.

The optimal PRP concentration range was identified as 600-900 x 10^6/L, with 3-5 injections at 7-14-day intervals yielding the best results. Early intervention, particularly in KL grade I-II patients, was associated with superior outcomes. The neural network model accurately predicted treatment responses based on patient characteristics and disease factors.

Key Takeaways:

  • PRP injections demonstrated comparable pain relief to HA but superior functional improvement in KOA patients.
  • PRP showed no significant difference in efficacy as monotherapy compared to corticosteroids but enhanced outcomes when used in combination.
  • PRP outperformed physical therapy and exercise therapy in both pain control and functional improvement.
  • The optimal PRP concentration range was identified as 600-900 x 10^6/L.
  • 3-5 injections at 7-14-day intervals yielded the best results.
  • Early intervention, particularly in KL grade I-II patients, was associated with superior outcomes.
  • The neural network model accurately predicted treatment responses based on patient characteristics and disease factors.
  • The study emphasized the importance of addressing limitations in long-term follow-up data, standardizing evaluation criteria, and exploring the clinical application of artificial intelligence techniques to enhance the precision and effectiveness of PRP therapy for KOA.

Statistics:

  • 28 RCTs with a total of 3,246 KOA patients were included in the systematic review and meta-analysis.
  • PRP demonstrated superior functional improvement compared to HA (p 0.05).
  • PRP outperformed physical therapy and exercise therapy in both pain control and functional improvement (p < 0.01).
  • The optimal PRP concentration range was identified as 600-900 x 10^6/L.
  • 3-5 injections at 7-14-day intervals yielded the best results.

Sources:

  • Efficacy and safety of platelet-rich plasma injections for the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. European Journal of Medical Research, 2025;30(1):992.
  • First Affiliated Hospital of Heilongjiang University of Chinese Medicine.
  • Chengjing Wang, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, People's Republic of China.

Read more